Page last updated: 2024-11-08

serine and Disease Exacerbation

serine has been researched along with Disease Exacerbation in 74 studies

Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the effects of the proteasome inhibitor bortezomib on tumor growth in patients with advanced colorectal cancer, and to explore the relationship between correlative studies and clinical outcome."9.11A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer. ( Birle, D; Degendorfer, P; Hedley, D; Mackay, H; Mackenzie, M; Major, P; Moore, M; Nicklee, T; Oza, A; Siu, L; Townsley, C; Tsao, MS; Vincent, M; Wright, J, 2005)
"Melanoma is a disease that primarily arises in the skin but is a derivative of the neural crest."5.43Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma. ( Carter, JH; Colligan, BM; Deddens, JA; Douglass, LE; Graff, JR; Hawkins, E; Jones, J; Lewis, TG; Lucas, D; Pemberton, JO; Spaulding, NR, 2016)
"To evaluate the effects of the proteasome inhibitor bortezomib on tumor growth in patients with advanced colorectal cancer, and to explore the relationship between correlative studies and clinical outcome."5.11A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer. ( Birle, D; Degendorfer, P; Hedley, D; Mackay, H; Mackenzie, M; Major, P; Moore, M; Nicklee, T; Oza, A; Siu, L; Townsley, C; Tsao, MS; Vincent, M; Wright, J, 2005)
"O-GlcNAcylation of ribosomal receptor for activated C-kinase 1 at the amino acid serine122 promotes its stability, ribosome localization and interaction with the protein kinase, PKCβII, thus driving the translation of oncogenes and tumorigenesis of hepatocellular carcinoma."3.88O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis. ( Duan, F; Gu, J; Guo, X; Jia, D; Liu, F; Ren, S; Ruan, Y; Song, S; Wang, L; Wu, H; Wu, W, 2018)
"A common threonine481serine polymorphism (T481S) has been shown in vitro to strongly activate the chloride channel Kb (CLC-Kb) expressed in the kidney, and the 481S allele has been associated with human hypertension."3.74The functional variant of the CLC-Kb channel T481S is not associated with blood pressure or hypertension in Swedes. ( Almgren, P; Berglund, G; Fava, C; Guidi, GC; Melander, O; Montagnana, M; Rosberg, L, 2007)
" Based on this small study, L-serine appears to be generally safe for patients with ALS."2.84Phase I clinical trial of safety of L-serine for ALS patients. ( Banack, SA; Bradley, WG; Cox, PA; Flynn, LE; Forshew, DA; Katz, JS; Levine, TD; Metcalf, JS; Miller, RG; Moore, DH; Saperstein, DS, 2017)
"Meningiomas are common brain tumours that are usually defined by benign clinical course."1.62Metabolic alterations in meningioma reflect the clinical course. ( Beck, J; Daka, K; Delev, D; Grauvogel, J; Heiland, DH; Krüger, MT; Masalha, W; Pompe, N; Schnell, O; Weber, S; Woerner, J, 2021)
"Alzheimer's disease is characterized by accumulation of amyloid plaques and tau aggregates in several cortical brain regions."1.48Phosphorylation of different tau sites during progression of Alzheimer's disease. ( Attems, J; Daum, G; Flunkert, S; Hoeller, C; Hutter-Paier, B; Kerschbaumer, B; Loeffler, T; Neddens, J; Niederkofler, V; Temmel, M, 2018)
"The expression of ALX4 in breast cancer cell lines and patients' tissues were detected by RT-PCR, qPCR and western blot."1.46ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway. ( Cao, J; Chen, H; Han, F; Hao, X; Huang, Y; Jiang, X; Liu, J; Liu, W; Yang, J; Yin, L; Zhang, H, 2017)
"Melanoma is a disease that primarily arises in the skin but is a derivative of the neural crest."1.43Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma. ( Carter, JH; Colligan, BM; Deddens, JA; Douglass, LE; Graff, JR; Hawkins, E; Jones, J; Lewis, TG; Lucas, D; Pemberton, JO; Spaulding, NR, 2016)
" We found that S421 phosphorylation mitigates neurodegeneration by increasing proteasome-dependent turnover of mHTT and reducing the presence of a toxic mHTT conformer."1.43Serine 421 regulates mutant huntingtin toxicity and clearance in mice. ( Daub, AC; Finkbeiner, S; Gu, X; Humbert, S; Kratter, IH; Lau, A; Masliah, E; Osmand, A; Saudou, F; Steffan, JS; Tsvetkov, AS; Weiberth, KF; Yang, XW; Zahed, H, 2016)
"We apply multiple prostate cancer cell models to demonstrate that enzalutamide induces differential activation of protein phosphatase-1 (PP-1) and Akt kinase depending on the gene context of cancer cells."1.42AR-v7 protein expression is regulated by protein kinase and phosphatase. ( Dong, X; Gleave, ME; Li, Y; Rennie, PS; Xie, N, 2015)
"A panel of HNSCC cell lines was determined with anoikis assays, and orthotopic mouse experiments were performed."1.39Serine substitution of proline at codon 151 of TP53 confers gain of function activity leading to anoikis resistance and tumor progression of head and neck cancer cells. ( Brennan, RG; Jasser, SA; Myers, JN; Sano, D; Xie, TX; Zhao, M; Zhou, G, 2013)
"Mucopolysaccharidosis type IIIA (MPS IIIA, Sanfilippo A syndrome) is caused by mutations in the N-sulfoglucosamine sulfohydrolase (SGSH) gene and the resulting defective lysosomal degradation of the glycosaminoglycan heparan sulfate."1.35The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). ( Braulke, T; Gal, A; Kossow, K; Meyer, A; Mühlhausen, C; Muschol, N; Steglich, C; Ullrich, K, 2008)
"Immunohistochemical staining of primary breast cancer biopsies (n = 290) was carried out using antibodies specific for ER phosphorylated at Ser(167) and for phosphorylated p44/p42 mitogen-activated protein kinase (MAPK), phosphorylated p90RSK, and phosphorylated AKT."1.34Phosphorylation of estrogen receptor-alpha at Ser167 is indicative of longer disease-free and overall survival in breast cancer patients. ( Ali, S; Coombes, RC; Jiang, J; Kulinskaya, E; Peston, D; Sarwar, N; Shousha, S, 2007)
" We conclude that SNPs in PPARD modify the conversion from IGT to type 2 diabetes, particularly in combination with the SNPs of PGC-1A and PPARG2."1.33Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. ( Andrulionyte, L; Chiasson, JL; Laakso, M; Peltola, P, 2006)
"They presented with congenital microcephaly, severe psychomotor retardation and intractable seizures."1.31Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. ( de Koning, TJ; Jaeken, J; Pineda, M; Poll-The, BT; van der Knaap, MS; Van Maldergem, L, 2000)
"Mutation of the adenomatous polyposis coli (APC) gene and the subsequent dysregulation of beta-catenin are well-documented abnormalities in familial adenomatous polyposis (FAP), as well as sporadic polyposis."1.31Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. ( Dedhar, S; Dupuis, B; Gallinger, S; Gray, V; Malik, S; Marotta, A; Owen, D; Salh, B; Sanghera, J; Tan, C, 2001)

Research

Studies (74)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's29 (39.19)29.6817
2010's39 (52.70)24.3611
2020's6 (8.11)2.80

Authors

AuthorsStudies
Rossi, M1
Altea-Manzano, P1
Demicco, M1
Doglioni, G1
Bornes, L1
Fukano, M1
Vandekeere, A1
Cuadros, AM1
Fernández-García, J1
Riera-Domingo, C1
Jauset, C1
Planque, M1
Alkan, HF1
Nittner, D1
Zuo, D1
Broadfield, LA1
Parik, S1
Pane, AA1
Rizzollo, F1
Rinaldi, G1
Zhang, T1
Teoh, ST1
Aurora, AB1
Karras, P1
Vermeire, I1
Broekaert, D1
Elsen, JV1
Knott, MML1
Orth, MF1
Demeyer, S1
Eelen, G1
Dobrolecki, LE1
Bassez, A1
Brussel, TV1
Sotlar, K1
Lewis, MT1
Bartsch, H1
Wuhrer, M1
Veelen, PV1
Carmeliet, P1
Cools, J1
Morrison, SJ1
Marine, JC1
Lambrechts, D1
Mazzone, M1
Hannon, GJ1
Lunt, SY1
Grünewald, TGP1
Park, M1
Rheenen, JV1
Fendt, SM1
Park, SM1
Seo, EH1
Bae, DH1
Kim, SS1
Kim, J1
Lin, W1
Kim, KH1
Park, JB1
Kim, YS1
Yin, J1
Kim, SY1
Padilla-Mendoza, JR1
Contis-Montes de Oca, A1
Rodríguez, MA1
López-Casamichana, M1
Bolaños, J1
Quintas-Granados, LI1
Reyes-Hernández, OD1
Fragozo-Sandoval, F1
Reséndiz-Albor, AA1
Arellano-Gutiérrez, CV1
López-Reyes, I1
Esposito, M1
Akman, HB1
Giron, P1
Ceregido, MA1
Schepers, R1
Ramos Paez, LC1
La Monaca, E1
De Greve, J1
Coux, O1
De Trez, C1
Lindon, C1
Gutierrez, GJ1
Masalha, W1
Daka, K1
Woerner, J1
Pompe, N1
Weber, S1
Delev, D1
Krüger, MT1
Schnell, O1
Beck, J1
Heiland, DH1
Grauvogel, J1
Bonelli, R1
Ansell, BRE1
Lotta, L1
Scerri, T1
Clemons, TE1
Leung, I1
Peto, T1
Bird, AC1
Sallo, FB1
Langenberg, C1
Bahlo, M1
Tsai, CL1
Jung, SM1
Chi, LM1
Tsai, CN1
Lin, CY1
Chao, A1
Lee, YS1
Wu, Q1
Li, J1
Sun, S2
Chen, X2
Zhang, H2
Li, B1
Zeng, S1
Xie, X2
Xiao, YF1
Tang, B1
Hu, CJ1
Wang, SM1
Wu, YY1
Dong, H1
Li, BS1
Yang, SM1
Bui, NL1
Pandey, V1
Zhu, T1
Ma, L1
Lobie, PE1
Yang, J1
Han, F1
Liu, W1
Chen, H1
Hao, X1
Jiang, X1
Yin, L1
Huang, Y3
Cao, J1
Liu, J1
Duan, F1
Wu, H1
Jia, D1
Wu, W1
Ren, S1
Wang, L3
Song, S1
Guo, X1
Liu, F1
Ruan, Y1
Gu, J1
Neddens, J1
Temmel, M1
Flunkert, S1
Kerschbaumer, B1
Hoeller, C1
Loeffler, T1
Niederkofler, V1
Daum, G1
Attems, J1
Hutter-Paier, B1
Ranek, MJ1
Kokkonen-Simon, KM1
Chen, A1
Dunkerly-Eyring, BL1
Vera, MP1
Oeing, CU1
Patel, CH1
Nakamura, T3
Zhu, G1
Bedja, D1
Sasaki, M1
Holewinski, RJ1
Van Eyk, JE1
Powell, JD1
Lee, DI1
Kass, DA1
Szybowska, P1
Kostas, M1
Wesche, J1
Wiedlocha, A1
Haugsten, EM1
Hesaka, A1
Yasuda, K1
Sakai, S1
Yonishi, H1
Namba-Hamano, T1
Takahashi, A1
Mizui, M1
Hamase, K1
Matsui, R1
Mita, M1
Horio, M1
Isaka, Y1
Kimura, T1
Xie, TX1
Zhou, G1
Zhao, M1
Sano, D1
Jasser, SA1
Brennan, RG1
Myers, JN1
Li, Y2
Xu, S1
Jiang, B1
Cohen, RA1
Zang, M1
Onishi, T1
Matsumoto, Y1
Hattori, M1
Obayashi, Y1
Nakamura, K1
Yano, T1
Horiguchi, T1
Iwashita, H1
Bian, Y1
Wang, Z1
Xu, J1
Zhao, W1
Cao, H1
Zhang, Z2
Zhang, N1
Döppler, H1
Bastea, L1
Borges, S1
Geiger, X1
Storz, P1
Xie, N1
Gleave, ME1
Rennie, PS1
Dong, X1
Carter, JH1
Deddens, JA1
Spaulding, NR1
Lucas, D1
Colligan, BM1
Lewis, TG1
Hawkins, E1
Jones, J1
Pemberton, JO1
Douglass, LE1
Graff, JR1
Kratter, IH1
Zahed, H1
Lau, A1
Tsvetkov, AS1
Daub, AC1
Weiberth, KF1
Gu, X1
Saudou, F1
Humbert, S1
Yang, XW1
Osmand, A1
Steffan, JS1
Masliah, E1
Finkbeiner, S1
Levine, TD1
Miller, RG2
Bradley, WG1
Moore, DH1
Saperstein, DS1
Flynn, LE1
Katz, JS1
Forshew, DA1
Metcalf, JS1
Banack, SA1
Cox, PA1
Samanta, D1
Semenza, GL1
Patek, S1
Willder, J1
Heng, J1
Taylor, B1
Horgan, P1
Leung, H1
Underwood, M1
Edwards, J1
Lin, H1
Hu, H1
Duan, W1
Liu, Y3
Tan, G1
Li, Z1
Deng, B1
Song, X1
Wang, W1
Wen, D1
Wang, Y3
Li, C2
Liu, P2
Li, R1
Antonov, AA1
Li, W1
Hua, Y1
Guo, H1
Chen, L1
Tian, Y1
Xu, F1
Zhu, Y1
Sakurai, H1
Cheng, C2
Ji, Y1
Zhao, Y1
Zou, L1
Shen, A2
Kang, HJ1
Lee, H1
Choi, HJ1
Youn, JH1
Shin, JS1
Ahn, YH1
Yoo, JS1
Paik, YK1
Kim, H1
Kadoyama, K1
Funakoshi, H1
Ohya-Shimada, W1
Matsumoto, K1
Matsuyama, S1
Teofili, L1
Giona, F1
Torti, L1
Cenci, T1
Ricerca, BM1
Rumi, C1
Nunes, V1
Foà, R1
Leone, G1
Martini, M1
Larocca, LM1
Walker, LA1
Walker, JS1
Ambler, SK1
Buttrick, PM1
Doi, H1
Koyano, S1
Miyatake, S1
Matsumoto, N1
Kameda, T1
Tomita, A1
Miyaji, Y1
Suzuki, Y1
Sawaishi, Y1
Kuroiwa, Y1
Xu, YM1
Zhu, F1
Cho, YY1
Carper, A1
Peng, C1
Zheng, D1
Yao, K1
Lau, AT1
Zykova, TA1
Kim, HG1
Bode, AM1
Dong, Z1
Zheng, HC1
Xu, XY1
Xia, P1
Yu, M1
Takahashi, H1
Takano, Y1
Bertea, M1
Rütti, MF1
Othman, A1
Marti-Jaun, J1
Hersberger, M1
von Eckardstein, A1
Hornemann, T1
Argyriou, P1
Papageorgiou, SG1
Panteleon, V1
Psyrri, A1
Bakou, V1
Pappa, V1
Spathis, A1
Economopoulou, P1
Papageorgiou, E1
Economopoulos, T1
Rontogianni, D1
Zhou, J1
Broe, M1
Anderson, JP1
Gai, WP1
Milward, EA1
Porritt, M1
Howells, D1
Hughes, AJ1
Wang, X1
Halliday, GM1
Lim, Y1
Kehm, VM1
Lee, EB1
Soper, JH1
Trojanowski, JQ1
Lee, VM1
Fuster, JJ1
González-Navarro, H1
Vinué, A1
Molina-Sànchez, P1
Andrés-Manzano, MJ1
Nakayama, KI1
Nakayama, K1
Díez-Juan, A1
Bernad, A1
Rodríguez, C1
Martínez-González, J1
Andrés, V1
Thompson, M1
Marecki, JC1
Marinesco, S1
Labrie, V1
Roder, JC1
Barger, SW1
Crow, JP1
de Calignon, A1
Polydoro, M1
Suárez-Calvet, M1
William, C1
Adamowicz, DH1
Kopeikina, KJ1
Pitstick, R1
Sahara, N1
Ashe, KH1
Carlson, GA1
Spires-Jones, TL1
Hyman, BT1
Respress, JL1
van Oort, RJ1
Li, N1
Rolim, N1
Dixit, SS1
deAlmeida, A1
Voigt, N1
Lawrence, WS1
Skapura, DG1
Skårdal, K1
Wisløff, U1
Wieland, T1
Ai, X1
Pogwizd, SM1
Dobrev, D1
Wehrens, XH2
Paul, P1
de Belleroche, J1
Azzedine, H1
Ruberg, M1
Ente, D1
Gilardeau, C1
Périé, S1
Wechsler, B1
Brice, A1
LeGuern, E1
Dubourg, O1
Dowjat, WK1
Kuchna, I1
Wisniewski, T1
Wegiel, J1
Verhoeven, K1
Coen, K1
De Vriendt, E1
Jacobs, A1
Van Gerwen, V1
Smouts, I1
Pou-Serradell, A1
Martin, JJ1
Timmerman, V1
De Jonghe, P1
Skildum, A1
Faivre, E1
Lange, CA1
Roesch, A1
Becker, B1
Meyer, S1
Hafner, C1
Wild, PJ1
Landthaler, M1
Vogt, T1
Matsumoto, M1
Furihata, M1
Kurabayashi, A1
Sasaguri, S1
Araki, K1
Hayashi, H1
Ohtsuki, Y1
Yanagawa, T1
Funasaka, T1
Tsutsumi, S1
Raz, T1
Tanaka, N1
Raz, A1
Cardone, RA1
Bagorda, A1
Bellizzi, A1
Busco, G1
Guerra, L1
Paradiso, A1
Casavola, V1
Zaccolo, M1
Reshkin, SJ1
Yang, SF1
Yuan, SS1
Yeh, YT1
Wu, MT1
Su, JH1
Hung, SC1
Chai, CY1
Mackay, H1
Hedley, D1
Major, P1
Townsley, C1
Mackenzie, M1
Vincent, M1
Degendorfer, P1
Tsao, MS1
Nicklee, T1
Birle, D1
Wright, J1
Siu, L1
Moore, M1
Oza, A1
Koul, D1
Shen, R1
Bergh, S1
Lu, Y1
de Groot, JF1
Liu, TJ1
Mills, GB1
Yung, WK1
Matsuzaki, K1
Andrulionyte, L1
Peltola, P1
Chiasson, JL1
Laakso, M1
Rajput, A1
Dickson, DW1
Robinson, CA1
Ross, OA1
Dächsel, JC1
Lincoln, SJ1
Cobb, SA1
Rajput, ML1
Farrer, MJ1
Ammosova, T1
Berro, R1
Jerebtsova, M1
Jackson, A1
Charles, S1
Klase, Z1
Southerland, W1
Gordeuk, VR1
Kashanchi, F1
Nekhai, S1
Fava, C1
Montagnana, M1
Almgren, P1
Rosberg, L1
Guidi, GC1
Berglund, G1
Melander, O1
Tumini, E1
Porcellini, E1
Chiappelli, M1
Conti, CM1
Beraudi, A1
Poli, A1
Caciagli, F1
Doyle, R1
Conti, P1
Licastro, F1
Coppedè, F1
Mancuso, M1
Lo Gerfo, A1
Carlesi, C1
Piazza, S1
Rocchi, A1
Petrozzi, L1
Nesti, C1
Micheli, D1
Bacci, A1
Migliore, L1
Murri, L1
Siciliano, G1
Chen-Izu, Y1
Ward, CW1
Stark, W1
Banyasz, T1
Sumandea, MP1
Balke, CW1
Izu, LT1
Jiang, J1
Sarwar, N1
Peston, D1
Kulinskaya, E1
Shousha, S1
Coombes, RC1
Ali, S1
Al-Kateb, H1
Boright, AP1
Mirea, L1
Sutradhar, R1
Mowjoodi, A1
Bharaj, B1
Liu, M1
Bucksa, JM1
Arends, VL1
Steffes, MW1
Cleary, PA1
Sun, W1
Lachin, JM1
Thorner, PS1
Ho, M1
McKnight, AJ1
Maxwell, AP1
Savage, DA1
Kidd, KK1
Kidd, JR1
Speed, WC1
Orchard, TJ1
Sun, L1
Bull, SB1
Paterson, AD1
Golan, MP1
Styczyńska, M1
Jóźwiak, K1
Walecki, J1
Maruszak, A1
Pniewski, J1
Lugiewicz, R1
Filipek, S1
Zekanowski, C1
Barcikowska, M1
Zhao, J1
Qin, J1
Shi, S1
Chen, M1
Gao, S1
Xiao, F1
Lu, Q1
Meyer, A1
Kossow, K1
Gal, A1
Steglich, C1
Mühlhausen, C1
Ullrich, K1
Braulke, T1
Muschol, N1
de Koning, TJ1
Jaeken, J1
Pineda, M1
Van Maldergem, L1
Poll-The, BT1
van der Knaap, MS1
Marotta, A1
Tan, C1
Gray, V1
Malik, S1
Gallinger, S1
Sanghera, J1
Dupuis, B1
Owen, D1
Dedhar, S1
Salh, B1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis: A Phase IIa Study[NCT03580616]Phase 243 participants (Actual)Interventional2018-10-24Terminated (stopped due to Study was terminated by the IRB due to continued noncompliance.)
A Phase II Study Of PS-341 In Patients With Metastatic Colorectal Cancer[NCT00052507]Phase 20 participants Interventional2003-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

5 reviews available for serine and Disease Exacerbation

ArticleYear
YAP/TAZ-mediated activation of serine metabolism and methylation regulation is critical for LKB1-deficient breast cancer progression.
    Bioscience reports, 2017, Oct-31, Volume: 37, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinase Kinases; Breast Neoplasms; Diseas

2017
Bad phosphorylation as a target of inhibition in oncology.
    Cancer letters, 2018, 02-28, Volume: 415

    Topics: Apoptosis; bcl-Associated Death Protein; Cell Survival; Disease Progression; Humans; Neoplasms; Phos

2018
Non-canonical Activation of Receptor Tyrosine Kinases in Cancer Progression.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2017, Volume: 137, Issue:2

    Topics: Antineoplastic Agents; Cell Movement; Cell Proliferation; Disease Progression; Drug Resistance, Neop

2017
The role of D-amino acids in amyotrophic lateral sclerosis pathogenesis: a review.
    Amino acids, 2012, Volume: 43, Issue:5

    Topics: Amyotrophic Lateral Sclerosis; Animals; Brain; D-Amino-Acid Oxidase; Disease Progression; Gene Expre

2012
Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis.
    Histology and histopathology, 2006, Volume: 21, Issue:6

    Topics: Adenocarcinoma; Adenoma; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Colorec

2006

Trials

3 trials available for serine and Disease Exacerbation

ArticleYear
Phase I clinical trial of safety of L-serine for ALS patients.
    Amyotrophic lateral sclerosis & frontotemporal degeneration, 2017, Volume: 18, Issue:1-2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Disease Progression; Dose

2017
A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-01, Volume: 11, Issue:15

    Topics: Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Agents; Biopsy; Boronic Acids; Bortezomi

2005
Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications G
    Diabetes, 2008, Volume: 57, Issue:1

    Topics: Alanine; Albuminuria; Amino Acid Substitution; Diabetic Nephropathies; Diabetic Retinopathy; Disease

2008

Other Studies

66 other studies available for serine and Disease Exacerbation

ArticleYear
PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.
    Nature, 2022, Volume: 605, Issue:7911

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression;

2022
Phosphoserine Phosphatase Promotes Lung Cancer Progression through the Dephosphorylation of IRS-1 and a Noncanonical L-Serine-Independent Pathway.
    Molecules and cells, 2019, Aug-31, Volume: 42, Issue:8

    Topics: A549 Cells; Animals; Disease Progression; Humans; Insulin Receptor Substrate Proteins; Lung Neoplasm

2019
Protein Phosphorylation in Serine Residues Correlates with Progression from Precancerous Lesions to Cervical Cancer in Mexican Patients.
    BioMed research international, 2020, Volume: 2020

    Topics: Adult; Cervix Uteri; Clusterin; Disease Progression; Female; Heat-Shock Proteins; Humans; Keratin-19

2020
USP13 controls the stability of Aurora B impacting progression through the cell cycle.
    Oncogene, 2020, Volume: 39, Issue:37

    Topics: Aurora Kinase B; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Disease Progression; Endopept

2020
Metabolic alterations in meningioma reflect the clinical course.
    BMC cancer, 2021, Mar-01, Volume: 21, Issue:1

    Topics: Aged; Algorithms; Biomarkers, Tumor; Choline; Cluster Analysis; Disease Progression; Female; Glycine

2021
Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression.
    Genome medicine, 2021, 03-09, Volume: 13, Issue:1

    Topics: Biosynthetic Pathways; Diabetes Mellitus, Type 2; Disease Progression; Endophenotypes; Genetic Loci;

2021
Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma.
    Aging, 2021, 05-23, Volume: 13, Issue:10

    Topics: Amino Acid Sequence; Animals; Cell Line, Tumor; Cell Movement; Disease Progression; Female; Glycogen

2021
Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression.
    Cancer letters, 2018, 01-01, Volume: 412

    Topics: Adult; Aged; Animals; Cell Movement; Disease Progression; Female; Genes, Tumor Suppressor; Humans; M

2018
ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.
    Journal of experimental & clinical cancer research : CR, 2017, Nov-28, Volume: 36, Issue:1

    Topics: beta Catenin; Breast Neoplasms; Disease Progression; DNA-Binding Proteins; Down-Regulation; Epigenes

2017
O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis.
    Journal of hepatology, 2018, Volume: 68, Issue:6

    Topics: Amino Acid Substitution; Animals; Carcinogens; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease

2018
Phosphorylation of different tau sites during progression of Alzheimer's disease.
    Acta neuropathologica communications, 2018, 06-29, Volume: 6, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Disease Progression; Female; Humans; Male; Middle

2018
PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
    Nature, 2019, Volume: 566, Issue:7743

    Topics: Animals; Autophagy; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Disease Progression; Enzy

2019
Cancer Mutations in FGFR2 Prevent a Negative Feedback Loop Mediated by the ERK1/2 Pathway.
    Cells, 2019, 05-29, Volume: 8, Issue:6

    Topics: Amino Acid Sequence; Cell Line, Tumor; Disease Progression; Epidermal Growth Factor; Feedback, Physi

2019
Dynamics of D-serine reflected the recovery course of a patient with rapidly progressive glomerulonephritis.
    CEN case reports, 2019, Volume: 8, Issue:4

    Topics: Acute Kidney Injury; Adult; Antibodies, Antineutrophil Cytoplasmic; Creatinine; Cyclophosphamide; Di

2019
Serine substitution of proline at codon 151 of TP53 confers gain of function activity leading to anoikis resistance and tumor progression of head and neck cancer cells.
    The Laryngoscope, 2013, Volume: 123, Issue:6

    Topics: Animals; Anoikis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Codon; Disease Prog

2013
Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Acetylation; AMP-Activated Protein Kinases; Animals; Aorta; Atherosclerosis; Biomarkers; Carrier Pro

2013
Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
    Neuroscience research, 2014, Volume: 80

    Topics: Age Factors; Animals; Axonal Transport; Cognition Disorders; Disease Progression; Exploratory Behavi

2014
Elevated Rictor expression is associated with tumor progression and poor prognosis in patients with gastric cancer.
    Biochemical and biophysical research communications, 2015, Aug-21, Volume: 464, Issue:2

    Topics: Biomarkers, Tumor; Carrier Proteins; Disease Progression; Female; Humans; Male; Middle Aged; Prognos

2015
Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Biotechnology and applied biochemistry, 2016, Volume: 63, Issue:6

    Topics: Acetylglucosamine; beta-N-Acetylhexosaminidases; Cell Line, Tumor; Cell Movement; Cell Proliferation

2016
The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma.
    Oncotarget, 2015, Oct-06, Volume: 6, Issue:30

    Topics: Breast Neoplasms; Carcinoma, Ductal; Cell Adhesion Molecules; Cell Line; Cell Line, Tumor; Cell Move

2015
AR-v7 protein expression is regulated by protein kinase and phosphatase.
    Oncotarget, 2015, Oct-20, Volume: 6, Issue:32

    Topics: Alternative Splicing; Benzamides; Cell Line, Tumor; Cytoplasm; Disease Progression; Gene Expression

2015
Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma.
    British journal of cancer, 2016, 02-16, Volume: 114, Issue:4

    Topics: Adult; Biomarkers, Tumor; Disease Progression; Eukaryotic Initiation Factor-4E; Female; Humans; Immu

2016
Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
    The Journal of clinical investigation, 2016, 09-01, Volume: 126, Issue:9

    Topics: Alanine; Animals; Aspartic Acid; Behavior, Animal; Chromosomes, Artificial, Bacterial; Disease Model

2016
Serine Synthesis Helps Hypoxic Cancer Stem Cells Regulate Redox.
    Cancer research, 2016, 11-15, Volume: 76, Issue:22

    Topics: Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Disease Progression; Humans; Neoplastic Stem Cel

2016
Androgen receptor phosphorylation status at serine 578 predicts poor outcome in prostate cancer patients.
    Oncotarget, 2017, Jan-17, Volume: 8, Issue:3

    Topics: Cell Line, Tumor; Cell Nucleus; Cytoplasm; Disease Progression; Humans; Male; Phosphorylation; Progn

2017
Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1
    Molecular neurobiology, 2018, Volume: 55, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; D-Amino-Acid Oxidase; Dependovirus; Disease Model

2018
Discovery of Metabolite Biomarkers for Acute Ischemic Stroke Progression.
    Journal of proteome research, 2017, 02-03, Volume: 16, Issue:2

    Topics: Aged; Betaine; Biomarkers; Disease Progression; Early Diagnosis; Female; Humans; Isoleucine; Male; M

2017
Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma.
    Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:7

    Topics: Adult; Aged; Carcinoma in Situ; COP9 Signalosome Complex; Cyclin-Dependent Kinase 2; Cyclin-Dependen

2009
Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers.
    Laboratory investigation; a journal of technical methods and pathology, 2009, Volume: 89, Issue:8

    Topics: Adenocarcinoma; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Nucleus; Colonic Neoplasms;

2009
Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
    Neuroscience research, 2009, Volume: 65, Issue:2

    Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Animals; Catalytic Domain; Central Nervous Syste

2009
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis.
    Haematologica, 2010, Volume: 95, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Asparagine; Child; Child, Presc

2010
Stage-specific changes in myofilament protein phosphorylation following myocardial infarction in mice.
    Journal of molecular and cellular cardiology, 2010, Volume: 48, Issue:6

    Topics: Animals; Disease Models, Animal; Disease Progression; Echocardiography; Hemodynamics; Mice; Myocardi

2010
Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings.
    Journal of the neurological sciences, 2010, Mar-15, Volume: 290, Issue:1-2

    Topics: Age of Onset; Amino Acid Substitution; Brain; Cerebrovascular Circulation; Disease Progression; DNA

2010
Extracellular signal-regulated kinase 8-mediated c-Jun phosphorylation increases tumorigenesis of human colon cancer.
    Cancer research, 2010, Apr-15, Volume: 70, Issue:8

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Colonic Neoplasms; D

2010
Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
    Human pathology, 2010, Volume: 41, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Line, Tumor; Disease Progres

2010
Deoxysphingoid bases as plasma markers in diabetes mellitus.
    Lipids in health and disease, 2010, Aug-16, Volume: 9

    Topics: Aged; Alanine; Biomarkers; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Diabeti

2010
Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1→HIF-1α pathway.
    Annals of hematology, 2011, Volume: 90, Issue:3

    Topics: Basic Helix-Loop-Helix Transcription Factors; Disease Progression; Female; Humans; Hypoxia-Inducible

2011
Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson's disease.
    Acta neuropathologica, 2011, Volume: 121, Issue:6

    Topics: Aged; Aged, 80 and over; alpha-Synuclein; Analysis of Variance; Disease Progression; Female; Frontal

2011
α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Jul-06, Volume: 31, Issue:27

    Topics: Acoustic Stimulation; Age Factors; alpha-Synuclein; Analysis of Variance; Animals; Animals, Newborn;

2011
Deficient p27 phosphorylation at serine 10 increases macrophage foam cell formation and aggravates atherosclerosis through a proliferation-independent mechanism.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:11

    Topics: Animals; Apolipoproteins E; Arteries; Atherosclerosis; Case-Control Studies; Cell Proliferation; Cyc

2011
Paradoxical roles of serine racemase and D-serine in the G93A mSOD1 mouse model of amyotrophic lateral sclerosis.
    Journal of neurochemistry, 2012, Volume: 120, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Disease Progression; Female; Humans;

2012
Propagation of tau pathology in a model of early Alzheimer's disease.
    Neuron, 2012, Feb-23, Volume: 73, Issue:4

    Topics: Age Factors; Alzheimer Disease; Animals; Disease Models, Animal; Disease Progression; Entorhinal Cor

2012
Role of RyR2 phosphorylation at S2814 during heart failure progression.
    Circulation research, 2012, May-25, Volume: 110, Issue:11

    Topics: Adult; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cardiomyopathy, Di

2012
Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene.
    Neuromuscular disorders : NMD, 2003, Volume: 13, Issue:4

    Topics: Adult; Arginine; Charcot-Marie-Tooth Disease; Disease Progression; DNA Mutational Analysis; Electrop

2003
A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations.
    Journal of Alzheimer's disease : JAD, 2004, Volume: 6, Issue:1

    Topics: Adult; Alzheimer Disease; Amino Acid Substitution; Amyloid beta-Protein Precursor; Animals; Brain; C

2004
SPTLC1 mutation in twin sisters with hereditary sensory neuropathy type I.
    Neurology, 2004, Mar-23, Volume: 62, Issue:6

    Topics: Acyl Coenzyme A; Acyltransferases; Belgium; Chromosome Mapping; Chromosomes, Human, Pair 9; Disease

2004
Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
    Molecular endocrinology (Baltimore, Md.), 2005, Volume: 19, Issue:2

    Topics: Binding Sites; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Culture Media, S

2005
Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2005, Volume: 18, Issue:4

    Topics: Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Melanocyt

2005
Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma.
    Oncology, 2004, Volume: 67, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Proli

2004
Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
    The Journal of biological chemistry, 2005, Mar-18, Volume: 280, Issue:11

    Topics: Amino Acid Sequence; Binding Sites; Casein Kinase II; Cell Line, Tumor; Cross-Linking Reagents; Cyto

2005
Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines.
    Molecular biology of the cell, 2005, Volume: 16, Issue:7

    Topics: Breast Neoplasms; Cation Transport Proteins; Cell Line, Tumor; Collagen; Culture Media, Serum-Free;

2005
The role of p-STAT3 (ser727) revealed by its association with Ki-67 in cervical intraepithelial neoplasia.
    Gynecologic oncology, 2005, Volume: 98, Issue:3

    Topics: Biomarkers, Tumor; Disease Progression; DNA-Binding Proteins; Female; Humans; Ki-67 Antigen; Phospho

2005
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:11

    Topics: Blotting, Western; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Movement; Cell Proliferation; C

2005
Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Diabetes, 2006, Volume: 55, Issue:7

    Topics: Amino Acid Substitution; Diabetes Mellitus, Type 2; Disease Progression; Female; Glucose Intolerance

2006
Parkinsonism, Lrrk2 G2019S, and tau neuropathology.
    Neurology, 2006, Oct-24, Volume: 67, Issue:8

    Topics: Aged; alpha-Synuclein; Brain; Cell Line; Disability Evaluation; Disease Progression; Female; Glycine

2006
Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription.
    Retrovirology, 2006, Nov-03, Volume: 3

    Topics: Cyclin-Dependent Kinase 2; Disease Progression; Gene Expression Regulation, Viral; Gene Products, ta

2006
The functional variant of the CLC-Kb channel T481S is not associated with blood pressure or hypertension in Swedes.
    Journal of hypertension, 2007, Volume: 25, Issue:1

    Topics: Adult; Blood Pressure; Chloride Channels; Cohort Studies; Cross-Sectional Studies; Disease Progressi

2007
The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients.
    Human psychopharmacology, 2007, Volume: 22, Issue:2

    Topics: Alleles; Alzheimer Disease; Apolipoprotein E4; Cognition Disorders; Disease Progression; Follow-Up S

2007
Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis.
    Neuroscience letters, 2007, Jun-13, Volume: 420, Issue:2

    Topics: Age Factors; Aged; Amino Acid Sequence; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Cyst

2007
Phosphorylation of RyR2 and shortening of RyR2 cluster spacing in spontaneously hypertensive rat with heart failure.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4

    Topics: Animals; Blotting, Western; Calcium; Cardiomegaly; Computer Simulation; Cyclic AMP-Dependent Protein

2007
Phosphorylation of estrogen receptor-alpha at Ser167 is indicative of longer disease-free and overall survival in breast cancer patients.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Oct-01, Volume: 13, Issue:19

    Topics: Breast Neoplasms; Cell Line, Tumor; Disease Progression; Disease-Free Survival; Estrogen Receptor al

2007
Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene.
    Experimental neurology, 2007, Volume: 208, Issue:2

    Topics: Adult; Alzheimer Disease; Brain; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Mo

2007
Temporal-spatial expressions of p27kip1 and its phosphorylation on Serine-10 after acute spinal cord injury in adult rat: Implications for post-traumatic glial proliferation.
    Neurochemistry international, 2008, Volume: 52, Issue:6

    Topics: Active Transport, Cell Nucleus; Acute Disease; Amino Acid Sequence; Animals; Astrocytes; Cell Prolif

2008
The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome).
    Human mutation, 2008, Volume: 29, Issue:5

    Topics: Adolescent; Adult; Child; Child, Preschool; Disease Progression; Female; Genotype; Humans; Hydrolase

2008
Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency.
    Neuropediatrics, 2000, Volume: 31, Issue:6

    Topics: Amino Acids; Carbohydrate Dehydrogenases; Cerebral Cortex; Child; Child, Preschool; Choline; Demyeli

2000
Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis.
    Oncogene, 2001, Sep-27, Volume: 20, Issue:43

    Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colonic Polyps; Diseas

2001